LD-2 disclosure · 3rd Quarter - Report
PERSONALIZED MEDICINE COALITION
Client
- Description
- Health care
- Location
- District of Columbia · United States of America
Registrant
- Description
- education and advocacy
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
2 issuesHealth Issues
Congressional Personalized Medicine Caucus H.R. 5989 Precision Medicine Answers for Kids Today Act H.R. 6000 Cures 2.0 H.R. 6875 Right Drug Dose Now Act H.R. 4128/S.2209 The VALID Act of 2021 and S.4348 FDASLA Act of 2022 H.R. 5376 Inflation Reduction Act of 2022 Standardizing Laboratory Practices in Pharmacogenomics (STRIPE) Collaborative Community CMS Medicare Advantage Request for Information CMS Calendar Year 2023 Physician Fee Schedule Proposed Rule CMS/CMMI Enhancing Oncology Model
LobbyistsCYNTHIA BENS · DAVID L DAVENPORT
Covered position (CYNTHIA BENS): Staff, Representative Paul E. Kanjorski
TargetedSENATE · HOUSE OF REPRESENTATIVES · Food & Drug Administration (FDA) · Centers For Medicare and Medicaid Services (CMS)
Budget/Appropriations
H.R.7667 the Food and Drug Amendments of 2022 S. 4348 the Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act of 2022 FY 2023 Food and Drug Administration Budget Priorities for CDRH, CDER and CBER FY 2023 National Institutes of Health Budget Priorities
LobbyistsCYNTHIA BENS · DAVID L DAVENPORT
Covered position (CYNTHIA BENS): Staff, Representative Paul E. Kanjorski
TargetedSENATE · HOUSE OF REPRESENTATIVES